XTPL published its financial results for 2023 during a video conference on 26 April. The company generated total revenues of PLN 15.5 million in 2023, including PLN 13.4 million in revenues from the sale of products and services. This is the highest result in the history of the company’s development and an increase of 21% […]

Read the full article

OncoSNAAT is a key project for Genomtec from the perspective of increasing the company’s value and a potential M&A transaction. For this project, the Company has secured funding in excess of PLN 10 million, which was successfully raised from the Company’s shareholders and a foreign investor. These funds guarantee the acceleration of the work. The […]

Read the full article

Terrabio, developer of the Terralyzer® mobile rtPCR genetic analyser, has officially completed its EMC assessment.This means that the unique and compact rtPCR platform Terralyzer® does not interfere with the operation of other devices and is immune to emissions from other devices. This is another milestone in the commercialisation of this solution. Follow the company’s progress […]

Read the full article
Talk – Action = Bullshit